John R Woollard Selected Research

John R Woollard Research Topics

Disease

8	Inflammation (Inflammations) 01/2020 - 08/2013
5	Obesity 01/2020 - 08/2013
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 02/2015
4	Fibrosis (Cirrhosis) 01/2019 - 06/2015
4	Hypoxia (Hypoxemia) 01/2019 - 09/2014
4	Hypertension (High Blood Pressure) 11/2017 - 11/2012
3	Solitary Kidney 01/2019 - 08/2013
3	Renovascular Hypertension (Goldblatt Syndrome) 01/2019 - 11/2012
3	Atherosclerosis 01/2018 - 10/2014
2	Ischemia 11/2019 - 11/2012
2	Hypercholesterolemia 01/2018 - 02/2015
2	Renal Artery Obstruction (Renal Artery Stenosis) 11/2012 - 03/2012
1	Pre-Eclampsia (Preeclampsia) 01/2019
1	Albuminuria 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Vascular Remodeling 01/2018
1	Body Weight (Weight, Body) 04/2016
1	Essential Hypertension 01/2016
1	Insulin Resistance 02/2015
1	Microvascular Rarefaction 09/2014
1	Acute Kidney Injury (Acute Renal Failure) 11/2012
1	Reperfusion Injury 11/2012
1	Hepatomegaly 12/2011
1	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 02/2009
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 02/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2009
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 11/2012
4	CytokinesIBA 01/2019 - 08/2013
4	CholesterolIBA 01/2018 - 10/2014
3	Lipocalin-2IBA 01/2019 - 11/2012
3	FructoseIBA 04/2016 - 08/2013
3	salicylhydroxamic acid (SHAM)IBA 04/2015 - 08/2013
2	Biological ProductsIBA 01/2020 - 10/2016
2	Furosemide (Lasix)FDA LinkGeneric 01/2019 - 03/2012
2	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2018 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 02/2015
2	SubtilisinIBA 01/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 11/2012
2	Mitochondrial DNA (mtDNA)IBA 11/2017 - 01/2016
2	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2016 - 04/2015
2	Cardiolipins (Cardiolipin)IBA 01/2016 - 09/2014
1	SiliconesIBA 11/2019
1	urate transporterIBA 01/2019
1	nephrinIBA 01/2019
1	activin AIBA 01/2019
1	AC133 AntigenIBA 01/2019
1	Iothalamic Acid (Iotalamic Acid)FDA Link 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	Monocyte Chemoattractant ProteinsIBA 01/2019
1	ProteomeIBA 01/2019
1	Activins (Activin)IBA 01/2019
1	Peptides (Polypeptides)IBA 03/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	CollagenIBA 11/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	AntioxidantsIBA 01/2017
1	Oxygen (Dioxygen)IBA 06/2015
1	IsoprostanesIBA 04/2015
1	LipidsIBA 02/2015
1	erucylphosphocholineIBA 09/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013
1	Mitochondrial Permeability Transition PoreIBA 11/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2012
1	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 11/2012
1	EpitopesIBA 12/2011
1	ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA 02/2009
1	polycystic kidney disease 1 proteinIBA 02/2009
1	polycystic kidney disease 2 proteinIBA 02/2009

Therapy/Procedure

2	Therapeutics 01/2019 - 11/2018
1	Autologous Transplantation 01/2020